Moderna (MRNA) News Today $36.94 -0.35 (-0.94%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period FY2025 EPS Estimates for Moderna Decreased by AnalystModerna, Inc. (NASDAQ:MRNA - Free Report) - Analysts at Leerink Partnrs dropped their FY2025 earnings per share estimates for shares of Moderna in a research note issued to investors on Sunday, November 17th. Leerink Partnrs analyst M. Foroohar now anticipates that the company will post earningsNovember 20 at 6:58 AM | marketbeat.comModerna’s Strategic Shift and Financial Outlook Leads to Sell Rating and Lowered Price TargetNovember 20 at 3:45 AM | markets.businessinsider.comModerna initiated with a Hold at BerenbergNovember 20 at 3:45 AM | msn.comModerna (NASDAQ:MRNA) Rating Increased to Strong-Buy at Hsbc Global ResNovember 20 at 3:39 AM | americanbankingnews.comModerna (NASDAQ:MRNA) Receives Overweight Rating from Piper SandlerNovember 20 at 2:51 AM | americanbankingnews.comBerenberg Bank Initiates Coverage on Moderna (NASDAQ:MRNA)Berenberg Bank initiated coverage on shares of Moderna in a research note on Tuesday. They set a "hold" rating and a $42.00 target price for the company.November 19 at 8:34 AM | marketbeat.comHsbc Global Res Upgrades Moderna (NASDAQ:MRNA) to Strong-BuyHsbc Global Res raised shares of Moderna from a "hold" rating to a "strong-buy" rating in a research report on Monday.November 19 at 6:31 AM | marketbeat.comModerna upgraded to Hold from Reduce at HSBCNovember 18 at 6:55 PM | markets.businessinsider.comModerna price target lowered to $69 from $115 at Piper SandlerNovember 18 at 6:55 PM | markets.businessinsider.comModerna stock climbs as HSBC upgrades to Buy on underestimated pipeline potentialNovember 18 at 6:55 PM | msn.comModerna's stock decline after RFK Jr's appointment makes an "attractive entry point": Piper SandlerNovember 18 at 6:55 PM | msn.comDeciphering Disruption: Inside Cathie Wood's Latest Plays (MRNA)Cathie Wood's recent stock market activity offers a glimpse into her evolving investment strategy and the potential of disruptive technologies.November 18 at 3:14 PM | marketbeat.comModerna Remains Confident Despite Political Concerns Over Vaccine Safety and HHS NominationNovember 18 at 2:01 PM | benzinga.comModerna (NASDAQ:MRNA) Sees Strong Trading Volume - Here's What HappenedModerna (NASDAQ:MRNA) Sees Strong Trading Volume - Still a Buy?November 18 at 1:17 PM | marketbeat.comModerna (NASDAQ:MRNA) Receives "Overweight" Rating from Piper SandlerPiper Sandler reiterated an "overweight" rating and issued a $69.00 price objective (down from $115.00) on shares of Moderna in a report on Monday.November 18 at 12:42 PM | marketbeat.comModerna (NASDAQ:MRNA) Raised to Buy at HSBCHSBC upgraded shares of Moderna from a "hold" rating to a "buy" rating and set a $58.00 target price for the company in a research note on Monday.November 18 at 8:32 AM | marketbeat.comKBC Group NV Sells 56,297 Shares of Moderna, Inc. (NASDAQ:MRNA)KBC Group NV trimmed its holdings in Moderna, Inc. (NASDAQ:MRNA - Free Report) by 40.6% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 82,346 shares of the company's stock after selling 56,2November 18 at 4:21 AM | marketbeat.comModerna, Inc. (NASDAQ:MRNA) Receives Average Rating of "Hold" from AnalystsModerna, Inc. (NASDAQ:MRNA - Get Free Report) has been given an average rating of "Hold" by the twenty-one research firms that are currently covering the stock, MarketBeat.com reports. Three analysts have rated the stock with a sell rating, fourteen have assigned a hold rating and four have givenNovember 18 at 1:49 AM | marketbeat.comWolfe Research Initiates Coverage of Moderna (MRNA) with Underperform RecommendationNovember 16, 2024 | msn.comFebruary 2025 Options Now Available For Moderna (MRNA)November 15, 2024 | nasdaq.comDemystifying Moderna: Insights From 16 Analyst ReviewsNovember 15, 2024 | benzinga.comModerna Shares Are Dipping Today: What's Going On?November 15, 2024 | benzinga.comModerna, Inc. (MRNA): Among 12 High Growth Large Cap Stocks to Buy NowNovember 15, 2024 | msn.comModerna, Inc. (MRNA) Guggenheim's Inaugural Healthcare Innovation Conference (Transcript)November 15, 2024 | seekingalpha.comThe Score: Spirit, Tesla, Moderna and More Stocks That Defined the WeekNovember 15, 2024 | wsj.comModerna (NASDAQ:MRNA) Shares Gap Down - Here's What HappenedModerna (NASDAQ:MRNA) Shares Gap Down - What's Next?November 15, 2024 | marketbeat.comModerna (NASDAQ:MRNA) Coverage Initiated by Analysts at Wolfe ResearchWolfe Research began coverage on shares of Moderna in a report on Friday. They issued an "underperform" rating and a $40.00 price objective on the stock.November 15, 2024 | marketbeat.comModerna And Other Vaccine Maker Stocks Tumble After Trump Taps RFK Jr. As HHS HeadNovember 14, 2024 | forbes.comVaccine-maker stocks like Moderna, Pfizer drop as Trump picks RFK Jr. to lead HHSNovember 14, 2024 | marketwatch.comSumitomo Mitsui Trust Group Inc. Has $107.89 Million Stock Holdings in Moderna, Inc. (NASDAQ:MRNA)Sumitomo Mitsui Trust Group Inc. lifted its holdings in Moderna, Inc. (NASDAQ:MRNA - Free Report) by 11.6% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,614,313 shares of the company's stock after buying an additional 1November 14, 2024 | marketbeat.comModerna, Inc. (MRNA) UBS Global Healthcare Conference (Transcript)November 13, 2024 | seekingalpha.comOVERSEA CHINESE BANKING Corp Ltd Boosts Stake in Moderna, Inc. (NASDAQ:MRNA)OVERSEA CHINESE BANKING Corp Ltd raised its position in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) by 1,123.8% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 28,845 shares of the company's stoNovember 13, 2024 | marketbeat.comPrincipal Financial Group Inc. Buys 15,218 Shares of Moderna, Inc. (NASDAQ:MRNA)Principal Financial Group Inc. boosted its position in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) by 4.2% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 379,451 shares of the company's stock after acqNovember 13, 2024 | marketbeat.comModerna Stock Outlook: Is Wall Street Bullish or Bearish?November 13, 2024 | msn.comNutcracker Therapeutics Introduces CRDMO Precision Biomanufacturing Solutions for mRNA Drug DevelopersNovember 12, 2024 | businesswire.comPoster Presentation at International mRNA Health Conference Showcases Clinical Evidence that PharmaJet® Delivery Systems Enable mRNA Vaccine DeliveryNovember 12, 2024 | businesswire.comInside Moderna’s Tech-Driven Culture: Insights From CIO Brad MillerNovember 12, 2024 | forbes.comBaillie Gifford & Co. Decreases Stock Holdings in Moderna, Inc. (NASDAQ:MRNA)Baillie Gifford & Co. reduced its holdings in Moderna, Inc. (NASDAQ:MRNA - Free Report) by 2.3% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 42,458,083 shares of the company's stock after selling 990,958 sNovember 12, 2024 | marketbeat.comModerna’s mRESVIA vaccine gains Health Canada approvalNovember 11, 2024 | msn.commRNA Synthesis & Manufacturing Market - Global Forecast to 2029November 11, 2024 | globenewswire.comModerna (NASDAQ:MRNA) Hits New 1-Year Low on Analyst DowngradeModerna (NASDAQ:MRNA) Sets New 52-Week Low Following Analyst DowngradeNovember 11, 2024 | marketbeat.comCautious Outlook on Moderna: Declining Vaccine Demand and Strategic Challenges Prompt Sell RatingNovember 11, 2024 | markets.businessinsider.comIntrinsic Value Partners LLC Acquires 24,505 Shares of Moderna, Inc. (NASDAQ:MRNA)Intrinsic Value Partners LLC lifted its holdings in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) by 91.1% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 51,392 shares of the company's stock after buying an additional 24,505 shares during the perNovember 11, 2024 | marketbeat.comPrivium Fund Management B.V. Purchases 17,221 Shares of Moderna, Inc. (NASDAQ:MRNA)Privium Fund Management B.V. lifted its position in Moderna, Inc. (NASDAQ:MRNA - Free Report) by 74.0% in the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 40,482 shares of the company's stock after acquiring an additional 17,221 shares duringNovember 10, 2024 | marketbeat.comSpiderRock Advisors LLC Increases Stake in Moderna, Inc. (NASDAQ:MRNA)SpiderRock Advisors LLC increased its holdings in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) by 1,442.5% in the third quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 26,917 shares of the company's stock after purchasing an additioNovember 10, 2024 | marketbeat.comRobeco Institutional Asset Management B.V. Sells 46,337 Shares of Moderna, Inc. (NASDAQ:MRNA)Robeco Institutional Asset Management B.V. reduced its holdings in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) by 51.3% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 44,011 shares of the company's stock afNovember 10, 2024 | marketbeat.comQRG Capital Management Inc. Decreases Stock Position in Moderna, Inc. (NASDAQ:MRNA)QRG Capital Management Inc. lowered its position in shares of Moderna, Inc. (NASDAQ:MRNA - Free Report) by 55.9% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 15,790 shares of the company's stock after selling 20,037November 9, 2024 | marketbeat.comCautious Outlook for Moderna Amid Market Challenges and Shrinking Growth ProspectsNovember 8, 2024 | markets.businessinsider.comModerna (NASDAQ:MRNA) Announces Quarterly Earnings ResultsModerna (NASDAQ:MRNA - Get Free Report) released its earnings results on Thursday. The company reported $0.03 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($1.89) by $1.92. Moderna had a negative return on equity of 21.35% and a negative net margin of 116.18%. The business had revenue of $1.90 billion for the quarter, compared to the consensus estimate of $1.25 billion. During the same quarter in the previous year, the business earned ($1.39) earnings per share. Moderna's quarterly revenue was up 3.8% on a year-over-year basis.November 8, 2024 | marketbeat.comModerna (NASDAQ:MRNA) Price Target Lowered to $111.00 at BarclaysBarclays dropped their price target on shares of Moderna from $125.00 to $111.00 and set an "overweight" rating for the company in a research report on Friday.November 8, 2024 | marketbeat.com Get Moderna News Delivered to You Automatically Sign up to receive the latest news and ratings for MRNA and its competitors with MarketBeat's FREE daily newsletter. Email Address Blackrock’s Sending THIS Crypto Higher on Purpose (Ad)It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development… YES, I WANT THE #1 CRYPTO NOW MRNA Media Mentions By Week MRNA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MRNA News Sentiment▼0.590.45▲Average Medical News Sentiment MRNA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MRNA Articles This Week▼3723▲MRNA Articles Average Week Get Moderna News Delivered to You Automatically Sign up to receive the latest news and ratings for MRNA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Neurocrine Biosciences News Bio-Techne News Repligen News Biogen News CRISPR Therapeutics News Denali Therapeutics News Takeda Pharmaceutical News BioNTech News Teva Pharmaceutical Industries News BeiGene News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MRNA) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Moderna, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Moderna With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
